Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.42 Analyst target: $34.83 Upside: 918.42%
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.